Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

News

Aus vaccines not frontrunners

Posted 11 September 2020

An Australian company has used artificial intelligence to predict which of the COVID-19 vaccines and treatments in clinical trials are most likely to succeed - and the two "frontunners" backed by the Australian Government weren't the winners.

In a major proof-of-concept study released exclusively to Pharma in Focus, health data analytics company Opyl has applied its software - which uses explainable artifical intelligence - to the 475 current vaccines and therapies targeting COVID-19.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Two new neuro drugs
Seizures, Parkinson's drugs registered
Special Report
Aust Covid Vaccine Tracker
Live updates on frontrunners, local trials and deals
Top of the Hill
Value in a post-Covid world
Time to reconsider what Aussies really want